Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H17F3N2O3 |
| Molecular Weight | 318.2916 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCO\N=C(/CCCC(O)=O)C1=CC=C(C=C1)C(F)(F)F
InChI
InChIKey=KUIZEDQDELAFQK-XDHOZWIPSA-N
InChI=1S/C14H17F3N2O3/c15-14(16,17)11-6-4-10(5-7-11)12(19-22-9-8-18)2-1-3-13(20)21/h4-7H,1-3,8-9,18H2,(H,20,21)/b19-12+
| Molecular Formula | C14H17F3N2O3 |
| Molecular Weight | 318.2916 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Fluvoxamino acid is a not pharmacologically active metabolite of fluvoxamine, drug, which used for the treatment of the obsessive compulsive disorder. The metabolism of fluvoxamine to fluvoxamino acid is involved a two-step oxidation process via an alcohol intermediate, fluvoxamino alcohol. CYP2D6 is responsible for the first-step oxidation of fluvoxamine to fluvoxamino alcohol, and alcohol dehydrogenase is involved in the second-step oxidation of fluvoxamino alcohol to the corresponding carbolic acid.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:49:57 UTC 2023
by
admin
on
Sat Dec 16 08:49:57 UTC 2023
|
| Record UNII |
B92JLW9803
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
84692-89-7
Created by
admin on Sat Dec 16 08:49:57 UTC 2023 , Edited by admin on Sat Dec 16 08:49:57 UTC 2023
|
PRIMARY | |||
|
B92JLW9803
Created by
admin on Sat Dec 16 08:49:57 UTC 2023 , Edited by admin on Sat Dec 16 08:49:57 UTC 2023
|
PRIMARY | |||
|
46781630
Created by
admin on Sat Dec 16 08:49:57 UTC 2023 , Edited by admin on Sat Dec 16 08:49:57 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
Indicates that CYP2D6 cataLyze; weak effect on inhibition of serotonin uptake
MAJOR
URINE
|
